Opti-SPECT/PET/CT: Five different imaging systems now combined

June 9, 2014

Taking their pick, biomedical researchers can now conduct five different imaging studies in one scan with a state-of-the-art preclinical molecular imaging system that scientists unveiled during the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting.

The imaging device allows single photon emission tomography (SPECT), (PET), X-ray computed tomography, fluorescence and bioluminescence imaging—powerful imaging techniques that provide different information about anatomy and physiological processes happening within the body. With the Opti-SPECT/PET/CT system, SPECT or PET information details drug distribution and improves interpretation of optical data, while bioluminescence and fluorescence characterize additional tumor properties. The tracer that are developed with the system will be used as a surgical guide for clinicians.

"We need to know as much as possible from our enemy: the tumor," Frederik Beekman, PhD, explained. Beekman is head of radiation technology and medical imaging and a professor at Delft University of Technology in Delft, The Netherlands. "This research proves that we can now obtain comprehensive data from five medical imaging systems in a single scan. It is minimally invasive and requires only a single dose of anesthesia."

Opti-SPECT/PET/CT is built on a small scale for preclinical studies and allows scientists to use a gamut of imaging methods including high resolution (SPECT and PET), radiological (CT) and optical imaging (fluorescence and bioluminescence). This means that information about organ function, structure and real-time physiological signals revealed within the light spectrum are all available in a synergistic fusion of advanced . The hybrid system includes high-performance cameras and an on-board dark room. The platform could be used for new drug discovery, especially for imaging agents that could be used intraoperatively for patients undergoing cancer surgery.

To test the device, researchers imaged models and then mice in multiple studies using a fluorescent dye optical agent and a agent that combines a radioactive particle with a chemical drug compound. The agent is injected and then imaged as it homes in on and interacts with specific bodily functions. In this case, that function is angiogenesis, or the development of new blood vessels, which often proliferate as a tumor grows. Results of the study confirmed the imaging system's functionality and proved that it was comparable to other add-on imaging platforms for .

Explore further: Molecular imaging gets to the root of rheumatoid arthritis

More information: Scientific Paper 484: Matthias van Oosterom, Rob Kreuger, Wendy Mahn, Frederik Beekman; RDM, Delft University of Technology, Delft, Netherlands; Tessa Buckle, Anton Bunschoten, Fijs Van Leeuwen, IMI, Leiden University Medical Center, Leiden, Netherlands; Lee Josephson, Massachusetts General Hospital and Harvard Medical School, Boston, MA, "Opti-SPECT: Preclinical module for integrated bioluminescence, fluorescence and radionuclide imaging," SNMMI's 61th Annual Meeting, June 7, 2014, St. Louis, Missouri.

Related Stories

Molecular imaging gets to the root of rheumatoid arthritis

June 9, 2014
Rheumatoid arthritis causes chronic pain for almost half of adults by the time they retire, but a new molecular imaging technique can visualize inflammation in the joints, giving doctors a clear read on chronic pain and possible ...

PET/MR is superior for verifying coronary arterial disease

June 9, 2014
Ischemic heart disease, a narrowing of the arteries supplying blood to the heart, is a leading cause of death throughout the world. A hybrid molecular imaging technique called positron emission tomography and magnetic resonance ...

Presurgical SPECT/CT shows more cancer than current standard

June 9, 2014
Startling data from an international multi-center trial provide growing evidence that sentinel node imaging is more effectively accomplished with hybrid functional imaging with single photon emission computed tomography and ...

PSMA-based imaging traces even treatment-resistant prostate cancer

June 9, 2014
Anti-androgen hormonal therapy, also called chemical castration, can be an important defense against further disease progression for patients with prostate cancer that has traveled and grown in other areas, or metastasized—but ...

SPECT/MR molecular imaging system makes its debut

June 11, 2013
The Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meetingmarks the unveiling of the successful application of a new preclinical hybrid molecular imaging system—single photon emission tomography and magnetic ...

Reconfigured hybrid imaging lowers radiation exposure

June 11, 2012
Molecular imaging is effective for providing information about disease processes, and today's hybrid imaging systems have additional computed tomography (CT) technology on board for alignment and imaging structures. While ...

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.